Timothy Taxter

Clinical validation of the tempus xT next-generation targeted oncology sequencing assay

Nike Beaubier, Robert Tell, Denise Lau et al. · Oncotarget · 2019 · 220 citations · Full text

Genetics, Pathology, Genomics +20

Integrated genomic profiling expands clinical options for patients with cancer

Nike Beaubier, Martin Bontrager, Robert Huether et al. · Nature Biotechnology · 2019 · 183 citations

Functional Genomics, Tumor Heterogeneity, Medicine +13

Cell-Free DNA and Circulating Tumor Cells: Comprehensive Liquid Biopsy Analysis in Advanced Breast Cancer

Giovanna Rossi, Zhaomei Mu, Alfred Rademaker et al. · Clinical Cancer Research · 2017 · 159 citations

Identification of Differential Tumor Subtypes of T1 Bladder Cancer

A. Gordon Robertson, Clarice S. Groeneveld, Brian J. Jordan et al. · European Urology · 2020 · 149 citations

T1 Bladder Cancer, Urology, Genitourinary Cancer +5

Integrating Next-Generation Sequencing with Morphology Improves Prognostic and Biologic Classification of Spitz Neoplasms

Victor L. Quan, Bin Zhang, Yongzhan Zhang et al. · Journal of Investigative Dermatology · 2020 · 82 citations · Full text

Bioinformatics, Oncology, Spitz Neoplasms +12